Published

AstraZeneca, Moi Teaching & Referral Hospital launch advanced molecular testing to improve lung cancer diagnosis in Kenya - The DailyMail

Summary by The DailyMail
AstraZeneca, in partnership with the Moi Teaching & Referral Hospital (MTRH), has launched an advanced molecular testing platform to enhance lung cancer diagnostics in Kenya. This collaboration, under AstraZeneca’s Cancer Care Africa (CCA) initiative, aims to strengthen the diagnostic capabilities in the public sector, providing Kenyan patients with access to cutting-edge technology to facilitate accurate diagnosis of lung cancer. As November ma…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)